DSS converts $12M Impact Biomedical debt into 31.9M shares of Impact common stock

DSS, INC.

DSS settled all outstanding debt owed by Impact Biomedical under a $12M original note and amendments.
In exchange, DSS received 31,939,778 freely tradeable shares of Impact's common stock.
Transaction closed on July 21, 2025; issuance of shares constituted full satisfaction of amounts owed to DSS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.